ALK-positive NSCLC

Explore clinical trials studying ALK-positive NSCLC. Study availability and eligibility vary by location and protocol.

5 public trials 1 recruiting study

Refine in advanced search Browse all conditions

ALK-positive NSCLC trial results

Recruiting

NCT07491497

Conditions: ALK-Positive Lung Cancer, ALK-positive NSCLC, ALK-positive Non-small Cell Lung Cancer
Locations: UCSF San Francisco, California, United States

University of Colorado Cancer Center Aurora, Colorado, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Dana Farber Cancer Center Boston, Massachusetts, United States

Not Yet Recruiting

NCT06904547

Completed

NCT04647110

Active, Not Recruiting

NCT02393625

Conditions: ALK-positive NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations: Mayo Clinic - Arizona Scottsdale, Arizona, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Massachusetts General Hospital Thoracic Oncolgoy Boston, Massachusetts, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

Active, Not Recruiting

NCT07567352

Conditions: ALK-positive Advanced NSCLC, ALK-positive NSCLC, ALK-positive Non-small-cell Lung Cancer, +11 more
Locations: Pfizer New York, United States